A reasonable approach includes: Baseline thyroid function tests (TSH and FT4) before starting GLP-1 therapy Repeat testing at 812 weeks after commencing treatment, particularly if significant weight loss occurs Further monitoring at 6 months , then annually if thyroid function remains stable Additional testing if symptoms of thyroid dysfunction develop After any levothyroxine dose change, NICE NG145 recommends re-checking thyroid function in 68 weeks to assess the adequacy of the adjustment
GLP-1 formulations significantly impact a patients appetite and digestion, necessitating changes to their eating habits
Psychological benefits of a preoperative educational bridging program for bariatric surgery: does face-to-face versus videoconference-based delivery make a difference
Heres how to handle it: Schedule Regular Check-ups: Keep up with regular visits to your doctor or diabetes specialist
Some of the common characteristics of people with type 2 diabetes are: increased thirst, increased occurrences of urination, unexplained weight loss, constant lethargy, and vision problems such as blurring of vision